Literature DB >> 11419859

Rofecoxib-induced renal dysfunction in a patient with compensated cirrhosis and heart failure.

Y Ofran, M Bursztyn, Z Ackerman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11419859     DOI： 10.1111/j.1572-0241.2001.03905.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN： 0002-9270            Impact factor:   10.864


× No keyword cloud information.
  4 in total

1.  Acute renal dysfunction associated with selective COX-2 inhibitor therapy.

Authors:  D Papaioannides; C Bouropoulos; D Sinapides; P Korantzopoulos; N Akritidis
Journal:  Int Urol Nephrol       Date:  2001       Impact factor: 2.370

Review 2.  Renal failure associated with the use of celecoxib and rofecoxib.

Authors:  Syed R Ahmad; Cindy Kortepeter; Allen Brinker; Min Chen; Julie Beitz
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

Review 3.  Pharmacokinetics of rofecoxib: a specific cyclo-oxygenase-2 inhibitor.

Authors:  Neal M Davies; Xiao W Teng; Neil M Skjodt
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

Review 4.  Nonsteroidal anti-inflammatory drugs and heart failure.

Authors:  Gysèle S Bleumink; Johannes Feenstra; Miriam C J M Sturkenboom; Bruno H Ch Stricker
Journal:  Drugs       Date:  2003       Impact factor: 9.546
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.